Literature DB >> 33089504

Oxygen depletion in FLASH ultra-high-dose-rate radiotherapy: A molecular dynamics simulation.

Ramin Abolfath1,2,3, David Grosshans4, Radhe Mohan1.   

Abstract

PURPOSE: We present a first-principles molecular dynamics (MD) simulation and expound upon a mechanism of oxygen depletion hypothesis to explain the mitigation of normal tissue injury observed in ultra-high-dose-rate (UHDR) FLASH radiotherapy.
METHODS: We simulated damage to a segment of DNA (also representing other biomolecules such as RNA and proteins) in a simulation box filled with H 2 O and O 2 molecules. Attoseconds physical interactions (ionizations, electronic, and vibrational excitations) were simulated by using the Monte Carlo track structure code Geant4-DNA. Immediately after ionization, ab initio Car-Parrinello molecular dynamics (CPMD) simulation was used to identify which H 2 O and O 2 molecules surrounding the DNA molecule were converted into reactive oxygen species (ROS). Subsequently, the femto- to nanosecond reactions of ROS were simulated by using MD with reactive force field (ReaxFF), to illustrate ROS merging into new types of non-reactive oxygen species (NROS) due to strong coupling among ROS. A coarse-grained model was constructed to describe the relevant collective phenomenon at the macroscopic level on ROS aggregation and formation of NROS agglomerates consistent with the underlying microscopic pathways obtained from MD simulations.
RESULTS: Time-dependent molecular simulations revealed the formation of metastable and transient spaghetti-like complexes among ROS generated at UHDR. At the higher ROS densities produced under UHDR, stranded chains (i.e., NROS) are produced, mediated through attractive electric polarity forces, hydrogen bonds, and magnetic dipole-dipole interactions among hydroxyl ( . OH ) radicals. NROS tend to be less mobile than cellular biomolecules as opposed to the isolated and sparsely dense ROS generated at conventional dose rates (CDR). We attribute this effect to the suppression of biomolecular damage induced per particle track. At a given oxygen level, as the dose rate increases, the size and number of NROS chains increase, and correspondingly the population of toxic ROS components decreases. Similarly, at a given high dose rate, as the oxygen level increases, so do the size and number of NROS chains until an optimum level of oxygen is reached. Beyond that level, the amount of oxygen present may be sufficient to saturate the production of NROS chains, thereby reversing the sparing effects of UHDRs.
CONCLUSIONS: We showed that oxygen depletion, hypothesized to lead to lower normal-tissue toxicity at FLASH dose rates, takes place within femto- to nanoseconds after irradiation. The mechanism is governed by the slow dynamics of chains of ROS complexes (NROS). Under physoxic (≈ 4-5% oxygen) conditions (i.e., in normal tissues), NROS are more abundant than in hypoxic conditions (e.g., <0.3% in parts of tumors), suggesting that biomolecular damage would be reduced in an environment with physoxic oxygen levels. Hence irradiation at UHDRs would be more effective for sparing physoxic normal tissues but not tumors containing regions of hypoxia. At much higher levels of oxygen (e.g., >10-15%), oxygen depletion by UHDRs may not be sufficient for tissue sparing.
© 2020 American Association of Physicists in Medicine.

Entities:  

Keywords:  FLASH radiation therapy; Monte Carlo; molecular dynamics; proton therapy

Mesh:

Substances:

Year:  2020        PMID: 33089504     DOI: 10.1002/mp.14548

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  7 in total

1.  Development of Ultra-High Dose-Rate (FLASH) Particle Therapy.

Authors:  Michele M Kim; Arash Darafsheh; Jan Schuemann; Ivana Dokic; Olle Lundh; Tianyu Zhao; José Ramos-Méndez; Lei Dong; Kristoffer Petersson
Journal:  IEEE Trans Radiat Plasma Med Sci       Date:  2021-06-22

2.  Using oxygen dose histograms to quantify voxelised ultra-high dose rate (FLASH) effects in multiple radiation modalities.

Authors:  Frank Van den Heuvel; Anna Vella; Francesca Fiorini; Mark Brooke; Mark Hill; Anderson Ryan; Tim Maughan; Amato Giaccia
Journal:  Phys Med Biol       Date:  2022-06-08       Impact factor: 4.174

Review 3.  The importance of hypoxia in radiotherapy for the immune response, metastatic potential and FLASH-RT.

Authors:  Eui Jung Moon; Kristoffer Petersson; Monica M Olcina
Journal:  Int J Radiat Biol       Date:  2021-11-02       Impact factor: 2.694

Review 4.  The Therapeutic Potential of FLASH-RT for Pancreatic Cancer.

Authors:  Chidi M Okoro; Emil Schüler; Cullen M Taniguchi
Journal:  Cancers (Basel)       Date:  2022-02-24       Impact factor: 6.639

5.  Development of a portable hypoxia chamber for ultra-high dose rate laser-driven proton radiobiology applications.

Authors:  Pankaj Chaudhary; Deborah C Gwynne; Boris Odlozilik; Aaron McMurray; Giuliana Milluzzo; Carla Maiorino; Domenico Doria; Hamad Ahmed; Lorenzo Romagnani; Aaron Alejo; Hersimerjit Padda; James Green; David Carroll; Nicola Booth; Paul McKenna; Satyabrata Kar; Giada Petringa; Roberto Catalano; Francesco P Cammarata; Giuseppe A P Cirrone; Stephen J McMahon; Kevin M Prise; Marco Borghesi
Journal:  Radiat Oncol       Date:  2022-04-15       Impact factor: 4.309

Review 6.  Mechanisms of FLASH effect.

Authors:  Binwei Lin; Dan Huang; Feng Gao; Yiwei Yang; Dai Wu; Yu Zhang; Gang Feng; Tangzhi Dai; Xiaobo Du
Journal:  Front Oncol       Date:  2022-09-23       Impact factor: 5.738

7.  Ultra-high dose rate dosimetry: Challenges and opportunities for FLASH radiation therapy.

Authors:  Francesco Romano; Claude Bailat; Patrik Gonçalves Jorge; Michael Lloyd Franz Lerch; Arash Darafsheh
Journal:  Med Phys       Date:  2022-05-07       Impact factor: 4.506

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.